What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His primary areas of study are Surgery, Internal medicine, Cancer, Radiation therapy and Colorectal cancer.
His Surgery research is multidisciplinary, incorporating perspectives in Clinical trial and Total mesorectal excision.
His Clinical trial study which covers Survival analysis that intersects with Data mining.
As part of his studies on Internal medicine, he frequently links adjacent subjects like Oncology.
His Oncology study combines topics in areas such as Young adult, Tamoxifen and Gynecology.
The study incorporates disciplines such as Clinical endpoint, Fluorouracil, Capecitabine and Hazard ratio in addition to Radiation therapy.
His most cited work include:
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer (3158 citations)
- Persistent epigenetic differences associated with prenatal exposure to famine in humans (2131 citations)
- Tutorial in biostatistics: competing risks and multi-state models. (1331 citations)
What are the main themes of his work throughout his whole career to date?
Hein Putter focuses on Internal medicine, Surgery, Oncology, Breast cancer and Cancer.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Cardiology.
His research brings together the fields of Clinical trial and Surgery.
His studies deal with areas such as Adjuvant therapy, Gynecology and Cohort as well as Oncology.
As part of his studies on Breast cancer, he often connects relevant areas like Chemotherapy.
He studies Total mesorectal excision, a branch of Colorectal cancer.
He most often published in these fields:
- Internal medicine (37.67%)
- Surgery (20.24%)
- Oncology (19.05%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (37.67%)
- Oncology (19.05%)
- Breast cancer (13.59%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Oncology, Breast cancer, Hazard ratio and Cancer.
His research on Internal medicine frequently links to adjacent areas such as Gastroenterology.
His Cancer study incorporates themes from Lymph node, Randomized controlled trial and Induction chemotherapy.
His studies examine the connections between Endometrial cancer and genetics, as well as such issues in Radiation therapy, with regards to Total mesorectal excision and Clinical endpoint.
His Chemotherapy study necessitates a more in-depth grasp of Surgery.
His biological study spans a wide range of topics, including Disease and Confidence interval.
Between 2017 and 2021, his most popular works were:
- Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial (182 citations)
- Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial (169 citations)
- Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer (99 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
The scientist’s investigation covers issues in Internal medicine, Hazard ratio, Surgery, Chemoradiotherapy and Chemotherapy.
Hein Putter combines subjects such as Gastroenterology and Oncology with his study of Internal medicine.
Hein Putter focuses mostly in the field of Oncology, narrowing it down to topics relating to Proportional hazards model and, in certain cases, Chemotherapy regimen.
His study in Hazard ratio is interdisciplinary in nature, drawing from both Transplantation and Cohort.
The various areas that Hein Putter examines in his Surgery study include Disease and Confidence interval.
His research in Radiation therapy intersects with topics in Clinical endpoint, Survival analysis and Total mesorectal excision.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
